LAZARD ASSET MANAGEMENT LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 20 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$7,092,000
-48.4%
7,000,000
-48.1%
0.01%
-37.5%
Q1 2022$13,736,000
-3.1%
13,500,0000.0%0.02%
+6.7%
Q4 2021$14,175,000
+17.7%
13,500,000
+17.4%
0.02%
+7.1%
Q3 2021$12,046,000
-2.8%
11,500,0000.0%0.01%0.0%
Q2 2021$12,391,000
+7.7%
11,500,000
+15.0%
0.01%0.0%
Q1 2021$11,500,000
-47.9%
10,000,000
-41.2%
0.01%
-50.0%
Q4 2020$22,080,000
+8.3%
17,000,000
-5.6%
0.03%
-3.4%
Q3 2020$20,397,000
+49.3%
18,000,000
+52.9%
0.03%
+38.1%
Q2 2020$13,660,000
+3.5%
11,773,0000.0%0.02%
-12.5%
Q1 2020$13,198,000
+323.1%
11,773,000
+292.4%
0.02%
+380.0%
Q3 2019$3,119,000
+281.3%
3,000,000
+200.0%
0.01%
+400.0%
Q3 2017$818,000
-90.1%
1,000,000
-90.5%
0.00%
-93.8%
Q2 2017$8,281,000
+32.1%
10,500,000
+7.7%
0.02%
+33.3%
Q1 2017$6,270,000
+6.2%
9,750,0000.0%0.01%0.0%
Q4 2016$5,904,000
+15.8%
9,750,000
+14.7%
0.01%
+20.0%
Q3 2016$5,100,0008,500,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 24,877,000$25,902,0001.06%
PFM Health Sciences, LP 19,807,000$20,605,0000.61%
Partner Investment Management, L.P. 193,000$201,0000.34%
DeepCurrents Investment Group LLC 4,430,000$4,581,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 20,454,000$21,253,0000.27%
FARALLON CAPITAL MANAGEMENT LLC 24,176,000$25,210,0000.19%
PALISADE CAPITAL MANAGEMENT, LP 2,300,000$2,381,0000.07%
Verition Fund Management LLC 1,415,000$1,472,0000.04%
CAPSTONE INVESTMENT ADVISORS, LLC 4,298,000$4,470,0000.03%
LOOMIS SAYLES & CO L P 248,482$8,404,0000.02%
View complete list of PTC THERAPEUTICS INC shareholders